Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
298060
vs
K
KOSPI 200
Over the past 12 months, SCM LifeScience Co Ltd has underperformed KOSPI 200, delivering a return of -59% compared to KOSPI 200's +119% growth.
Stocks Performance
298060 vs KOSPI 200
Performance Gap
298060 vs KOSPI 200
Performance By Year
298060 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SCM LifeScience Co Ltd
Glance View
SCM LifeScience is a South Korean biotechnology company focused on stem cell and regenerative medicine. It develops cell-based treatments and related medical products aimed at hospitals and clinics treating difficult conditions, especially where standard drugs may not work well. In simple terms, it tries to turn living cells into medicines that can help repair or calm damaged tissue. The company makes money by selling its own cell therapy products and by commercializing the technology behind them, which can include development work, manufacturing support, and partnerships with other healthcare groups. Its customers are mainly medical institutions and commercial partners in the life sciences field rather than ordinary consumers. What makes SCM LifeScience different is its place in the cell-therapy supply chain. Instead of making pills or generic devices, it works with living cells, a far more specialized and regulated business. That means its value comes from scientific know-how, manufacturing control, and the ability to move experimental stem cell treatments into real-world medical use.